Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KPT-9274 + Niacin |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KPT-9274 | KCP-9274 | NAMPT Inhibitor 7 | KPT-9274 is a dual inhibitor of PAK4 and NAMPT, which blocks the PAK4 and NAD pathways, possibly resulting in inhibition of tumor growth (PMID: 27390344, PMID: 31876149, PMID: 31795447). | |
| Niacin | Akotin | 3-Pyridinecarboxylic acid |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02702492 | Phase I | KPT-9274 KPT-9274 + Niacin | PAK4 and NAMPT in Patients With Solid MAlignancies or NHL (PANAMA) (PANAMA) | Terminated | USA | CAN | 0 |